[Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices]
[Page 77063]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22de06-103]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 26, 2006, and published in the Federal
Register on August 14, 2006, (71 FR 46514-46515), Applied Science Labs,
Division of Alltech Associates Inc., 2701 Carolean Industrial Drive,
State College, Pennsylvania 16801, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
4-Methylaminorex (cis isomer) (1590)....... I
Alpha-Ethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
2,5-dimethoxy-4-(n)-propylthiophenethylamin I
e (2C-T-7) (7348).
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
Alpha-methyltryptamine (AMT) (7432)........ I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-methoxy-N-,N-diisopropyltryptamine(5-MeO- I
DIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy) I
(7458).
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Methamphetamine (1105)..................... II
1-Phenylcylohexylamine (7460).............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexanecarboni- trile II
(8603).
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Meperidine intermediate-B (9233)........... II
Morphine (9300)............................ II
Noroxymorphone (9668)...................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical application only in clinical, toxicological and forensic
laboratories.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Applied Science Labs, Division of Alltech Associates Inc. to
manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated
Applied Science Labs, Division of Alltech Associates Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-21875 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P